Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Everstone’s plan to acquire Kenstar hits IBC roadblock

2018-07-03 livemint
Mumbai: Private equity (PE) firm Everstone Capital has put its plan to acquire Videocon Group-owned home appliances brand Kenstar on the backburner, two people close to the development said.
500696 HINDUNILVR 511389 VIDEOIND SBAZ

15
Market Update: Nifty pharma outperforms led by Aurobindo Pharma; PSU banks drag

2018-06-14 moneycontrol
The broader indices are trading on a negative note this Thursday afternoon with the Nifty shedding 67 points at 10,789 and the Sensex is down 200 points at 35,539.
GRASIM 500325 AUROPHARMA RELIANCE TCHQY 532755 511389 VIDEOIND TTNQY 535789 532540 532461 532483 RIGD HDFCBANK GAILF TV18BRDCST RLNIY SBAZ UBNC GRSJY JAGRAN 524804 IDKQY 532705 532800 TECHM CNRYY IBULHSGFIN GRSXY PNJZY HDB 500180 ARBQY GAILY 500300 TCS PNB CANBK

0
Videocon blames Modi, SC, Brazil for bad debt pile-up

2018-06-13 freepressjournal.in
Mumbai : Videocon Industries has blamed Prime Minister Narendra Modi, the Supreme Court of India and the Brazilian government after lenders led by the States Bank of India (SBI) took the company to bankruptcy court for failure to repay dues on its debt of around Rs 3,900 crore, according to a report.
511389 VIDEOIND

1
Bombay high court drops Videocon case against SBI, RBI

2018-06-13 livemint
Mumbai: The Bombay high court on Wednesday disposed of a petition filed in January by Videocon Industries Ltd, objecting to the initiation of bankruptcy proceedings against the company.
511389 VIDEOIND SBAZ

10
2018 crucial for insolvency code, says AZB’s Bahram Vakil

2018-06-12 livemint
Mumbai: The two lists of bad loan accounts referred by the Reserve Bank of India (RBI) for quick insolvency resolution account for over 40% of all non-performing assets (NPAs) in India’s banks. According to Bahram Vakil, co-founder of law firm AZB & Partners and one of the architects of the Insolvency and Bankruptcy Code (IBC), once these cases are resolved by the end of the year, it would be a “terrific achievement”, accomplished in record speed.
500470 TTST TATASTEEL TATLY BHUSANSTL UCLQY 532538 UCLQF 511389 VIDEOIND ULTRACEMCO 500055

0
Videocon Industries Limited - Updates

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
511389 VIDEOIND

19
Market Update: Pharma stocks extend gains with Lupin up 5%; TCS, RIL most active

2018-06-12 moneycontrol
The broader indices are trading on a positive note this Tuesday afternoon with the Nifty trading higher by 47 points at 10,834 and the Sensex added 177 points at 35,661.
500408 500325 AUROPHARMA RELIANCE TTQQY 532714 HINDUNILVR 511389 VIDEOIND IDBLZ HCL-INSYS CADILAHC TATACHEM 532960 JUSTDIAL 532321 535648 532187 532483 RIGD 500696 500179 BJJQY KEC 500770 RLNIY 500034 SBAZ UBNC 524804 INDUSINDBK IBVENTURES CDLYY CNRYY BAJFINANCE ARBQY TATAELXSI CANBK JSTQY

11
Market Update: PSU banks, pharma stocks rally with RIL up 1%; Infosys hits fresh 52-week high

2018-06-12 moneycontrol
The broader indices are trading on a positive note this Tuesday afternoon with the Nifty trading higher by 60 points at 10,848 and the Sensex added 214 points at 35,705.
500408 500325 AUROPHARMA RELIANCE 532714 511389 VIDEOIND HCL-INSYS CADILAHC 532321 532187 RIGD 500179 BJJQY KEC RLNIY 500034 SBAZ UBNC 524804 INDUSINDBK CDLYY BAJFINANCE ARBQY TATAELXSI

8
Videocon Industries hits record low on bankruptcy

2018-06-12 thehindubusinessline
Shares of Videocon Industries Ltd hit the lower limit, falling as much as 5 per cent to Rs 7.65, a record low. The bankruptcy court has initiated insolvency proceedings against Videocon, the consumer electronics firm said on Monday.
ICICIBANK 532174 IBN TRI 511389 VIDEOIND

0
Videocon Industries Limited - Corporate Insolvency Resolution Process

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
511389 VIDEOIND

0
Videocon Industries Limited - News Clarification

2018-06-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
511389 VIDEOIND

26

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...